RAPRIL
DCI : RAMIPRIL
Dosage 5 mg
Pharmaceutical form Scored tablet
Therapeutic class Cardiology-Engiology
B/30
Indications
Hypertension - Post-myocardial infarction complicated by heart failure. The long-term treatment with ramipril improves survival and reduces the risk of progression to severe heart failure - Prevention of cardiovascular complications in patients at high vascular risk (including diabetes and coronary), having a confirmed ischemic arterial disease. In this population, treatment with ramipril long-term survival was significantly improved by the HOPE study
Download the leaflet
